Shareholder alert: robbins llp is investigating acadia pharmaceuticals inc. (acad) on behalf of shareholders

San diego--(business wire)---- $acad #classaction--shareholder rights law firm robbins llp is investigating acadia pharmaceuticals inc. (nasdaq: acad) on behalf of shareholders to determine whether certain acadia officers and directors violated the securities exchange act of 1934 and breached their fiduciary duties to the company. acadia is developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia and major depressive disorder. if you suffered a loss due to
ACAD Ratings Summary
ACAD Quant Ranking